Awaiting product image

Article: Axicabtagene ciloleucel as new standard of care for second-line treatment of DLBCL patients: from pivotal data to real-world evidence

€3.03

SKU: product-article-44228 Category:

Description

Axicabtagene ciloleucel as new standard of care for second-line treatment of DLBCL patients: from pivotal data to real-world evidence

Reviews

There are no reviews yet.

Be the first to review “Article: Axicabtagene ciloleucel as new standard of care for second-line treatment of DLBCL patients: from pivotal data to real-world evidence”

Related products